Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Histogenics Cp (HSGX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Biotech and Cannabis Stocks That Are Emerging

HENDERSON, NV / ACCESSWIRE / February 13, 2019 / One you should research right away, BioRestorative Therapies, Inc. (BRTX), a life sciences company focused on stem cell-based therapies, is developing a...

ACB : 9.16 (-0.97%)
GWPH : 166.96 (+1.18%)
CRMD : 7.62 (-8.19%)
HSGX : 0.12 (unch)
Jonathan Lieber Joins Danforth Advisors as Managing Director

Danforth Advisors, LLC, a consulting firm providing operational accounting and finance support, together with CFO services, for private and public life science companies, today announced the appointment...

HSGX : 0.12 (unch)
Is Histogenics (HSGX) Outperforming Other Medical Stocks This Year?

Is (HSGX) Outperforming Other Medical Stocks This Year?

HSGX : 0.12 (unch)
Best Ways to Play Biotech Rally

HENDERSON, NV / ACCESSWIRE / January 23, 2019 / The market reached a level toward the end of last year where investors and analysts were throwing the "R" word (recession) around. The cause of this bearish...

CLDX : 5.29 (+7.09%)
GNMX : 0.21 (unch)
GERN : 1.68 (+2.44%)
DCTH : 0.2550 (-1.92%)
HSGX : 0.12 (unch)
The Next Big Biotech Breakout

HENDERSON, NV / ACCESSWIRE / January 8, 2019 / Celgene's major deal with Bristol-Myers Squibb seems to have woken up the sleeping giant that is the biotech market. Axsome announced positive trial data...

GNMX : 0.21 (unch)
ENDV : 0.0179 (+0.56%)
CELGZ : 1.16 (+0.50%)
HSGX : 0.12 (unch)
BMY : 48.34 (+1.79%)
AXSM : 14.34 (-12.24%)
Histogenics and FDA Conclude Discussions Regarding NeoCart(R) Phase 3 Clinical Trial Data and Regulatory Pathway

Histogenics Corporation (Histogenics) (Nasdaq: HSGX), today provided an update on the NeoCart regulatory pathway based on discussions with the U.S. Food and Drug Administration (the FDA). Based on the...

HSGX : 0.12 (unch)
Histogenics and FDA Continue to Discuss NeoCart(R) Phase 3 Clinical Trial Data and Potential Regulatory Pathway

Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored function, today provided an update on...

HSGX : 0.12 (unch)
New Research Coverage Highlights Intersections, PRGX Global, Ecology and Environment, Histogenics, SeaChange International, and TransAct Technologies -- Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Intersections, Inc. (NASDAQ:INTX),...

GLEC : 0.0025 (unch)
SEAC : 1.38 (unch)
PRGX : 8.04 (+0.63%)
EEI : 10.98 (+0.39%)
TACT : 8.69 (+1.05%)
INTX : 3.67 (unch)
HSGX : 0.12 (unch)
Histogenics: 1Q Earnings Snapshot

WALTHAM, Mass. (AP) _ Histogenics Corp. (HSGX) on Thursday reported a loss of $14.8 million in its first quarter.

HSGX : 0.12 (unch)
Histogenics Corporation Announces First Quarter 2018 Financial and Operating Results

â?' Top-line Superiority Data from NeoCart Phase 3 Clinical Trial and Potential Biologics License Application Submission on Track for Third Quarter of 2018 â?'

HSGX : 0.12 (unch)
Histogenics Corporation to Report First Quarter 2018 Financial Results on May 10, 2018

Histogenics Corporation (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored function, announced it will report its first quarter...

HSGX : 0.12 (unch)
Histogenics Corporation Announces the Appointment of Susan Washer to Its Board of Directors

Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies (RCTs) that may offer rapid-onset pain relief and restored function, today announced the appointment...

HSGX : 0.12 (unch)
Histogenics Corporation to Present at Upcoming Investor Conferences

Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored function, announced that Company Management...

HSGX : 0.12 (unch)

Van Meerten Stock Picks

Trilogy Metals - Pick of the Day
My Stock Pick of the Day belongs metal mining company Trilogy Metals(TMQ).
TMQ +0.09
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar